These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 807168)

  • 1. Proceedings: Pancreatic glucagon in diabetic ketoacidosis.
    Johnston DI; Bloom SR; O'Brien D
    Arch Dis Child; 1975 Apr; 50(4):329. PubMed ID: 807168
    [No Abstract]   [Full Text] [Related]  

  • 2. Hyperglucagonemia in diabetic ketoacidosis. Its prevalence and significance.
    Müller WA; Faloona GR; Unger RH
    Am J Med; 1973 Jan; 54(1):52-7. PubMed ID: 4629972
    [No Abstract]   [Full Text] [Related]  

  • 3. Efficacy of combined insulin and somatostatin infusion for the treatment of experimental diabetic ketoacidosis.
    Harano Y; Ohgaku S; Hidaka H; Takatsuki K; Shigeta Y
    Horm Metab Res; 1979 May; 11(5):338-42. PubMed ID: 113327
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of therapy on the nature and quantity of fuels oxidized during diabetic ketoacidosis.
    Owen OE; Trapp VE; Reichard GA; Mozzoli MA; Smith R; Boden G
    Diabetes; 1980 May; 29(5):365-72. PubMed ID: 6769726
    [No Abstract]   [Full Text] [Related]  

  • 5. [Insulin resistance and diabetic ketoacidosis].
    Alberti KG
    Journ Annu Diabetol Hotel Dieu; 1976 May; ():79-90. PubMed ID: 827649
    [No Abstract]   [Full Text] [Related]  

  • 6. Glucagon suppression with low-dose intramuscular insulin therapy in diabetic ketoacidosis.
    Onur K; Lala VR; Juan CS; AvRuskin TW
    J Pediatr; 1979 Feb; 94(2):307-11. PubMed ID: 105114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glucagon and diabetes. I. The failure of hyperglucagonaemia to influence the response of established diabetic ketoacidosis to therapy.
    Perry-Keene DA; Alford FP; Chisholm DJ; Findlay DM; Larkins RG; Martin FI
    Clin Endocrinol (Oxf); 1977 Jun; 6(6):417-23. PubMed ID: 407039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of glucagon in human diabetic ketoacidosis: studies using somatostatin.
    Gerich JE; Schneider VS; Lorenzi M; Tsalikian E; Karam JH; Bier DM; Forsham PH
    Clin Endocrinol (Oxf); 1976; 5 Suppl():299S-305S. PubMed ID: 829924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of diabetic ketoacidosis with low dose insulin.
    Kitabchi AE
    Adv Intern Med; 1978; 23():115-35. PubMed ID: 415525
    [No Abstract]   [Full Text] [Related]  

  • 10. Diabetic ketoacidosis: counter-regulatory hormones versus insulin in therapeutic response. Report of a case.
    Schade DS; Kaufman E; Eaton RP
    Rocky Mt Med J; 1977; 74(6):312-5. PubMed ID: 416484
    [No Abstract]   [Full Text] [Related]  

  • 11. Serial plasma growth hormone levels in 33 cases of severe diabetic ketoacidosis--effects of sodium nicotinate.
    Assan R; Tchobroutsky G
    Horm Metab Res; 1972 Sep; 4(5):317-21. PubMed ID: 4630328
    [No Abstract]   [Full Text] [Related]  

  • 12. Glucagon physiology and pathophysiology.
    Unger RH
    N Engl J Med; 1971 Aug; 285(8):443-9. PubMed ID: 4997492
    [No Abstract]   [Full Text] [Related]  

  • 13. Ketogenic action of glucagon in insulin-dependent diabetic subjects.
    Harano Y; Ohgaku S; Shimizu Y; Izumi K; Takahashi J
    Endocrinol Jpn; 1977 Apr; 24(2):121-8. PubMed ID: 406133
    [No Abstract]   [Full Text] [Related]  

  • 14. Serial plasma growth hormone levels in 33 diabetic patients in ketoacidosis coma: effect of sodium nicotinate.
    Assan R; Tchobroutsky G
    Isr J Med Sci; 1972 Jun; 8(6):866. PubMed ID: 4626317
    [No Abstract]   [Full Text] [Related]  

  • 15. Diabetic ketoacidosis: new concepts and trends in pathogenesis and treatment.
    Kreisberg RA
    Ann Intern Med; 1978 May; 88(5):681-95. PubMed ID: 417652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathophysiology of ketoacidosis in Type 2 diabetes mellitus.
    Linfoot P; Bergstrom C; Ipp E
    Diabet Med; 2005 Oct; 22(10):1414-9. PubMed ID: 16176205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The cerebrospinal fluid in diabetic ketoacidosis.
    Ohman JL; Marliss EB; Aoki TT; Munichoodappa CS; Khanna VV; Kozak GP
    N Engl J Med; 1971 Feb; 284(6):283-90. PubMed ID: 4992715
    [No Abstract]   [Full Text] [Related]  

  • 18. The alpha cell in diabetic ketoacidosis.
    Bartle B
    JAMA; 1973 Sep; 225(12):1533. PubMed ID: 4199183
    [No Abstract]   [Full Text] [Related]  

  • 19. Investigation of insulin resistance during diabetic ketoacidosis: role of counterregulatory substances and effect of insulin therapy.
    Ginsberg HN
    Metabolism; 1977 Oct; 26(10):1135-46. PubMed ID: 408581
    [No Abstract]   [Full Text] [Related]  

  • 20. Short-term of the artificial beta-cell (Biostator) on pancreatic glucagon response in insulin-dependent diabetic (IDDM).
    Ratzmann KP; Schneider U; Besch W; Heinke P
    Exp Clin Endocrinol; 1984 Jul; 84(1):91-8. PubMed ID: 6383851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.